Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Chongqing Pharscin Pharmaceutical Co Ltd cash flow-to-debt ratio. Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥833.94K could theoretically repay 0% of its total liabilities (CN¥287.66 Million) in one year. Check 002907 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Cash flow-to-debt ratio of Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. Historical debt coverage capacity for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Check Chongqing Pharscin Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2024)
Chongqing Pharscin Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Chongqing Pharscin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Chongqing Pharscin Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | CN¥161.77 Million | CN¥257.55 Million | ▼ -33.1% |
| 2023 | 0.94x | CN¥219.34 Million | CN¥233.53 Million | ▲ +1745.2% |
| 2022 | 0.05x | CN¥13.04 Million | CN¥256.28 Million | ▼ -68.9% |
| 2021 | 0.16x | CN¥82.85 Million | CN¥505.56 Million | ▼ -22.2% |
| 2020 | 0.21x | CN¥113.64 Million | CN¥539.59 Million | ▲ +81.0% |
| 2019 | 0.12x | CN¥65.92 Million | CN¥566.67 Million | ▼ -3.2% |
| 2018 | 0.12x | CN¥31.80 Million | CN¥264.72 Million | ▼ -75.6% |
| 2017 | 0.49x | CN¥81.34 Million | CN¥165.20 Million | ▲ +62.8% |
| 2016 | 0.30x | CN¥57.73 Million | CN¥190.91 Million | ▼ -20.6% |
| 2015 | 0.38x | CN¥66.10 Million | CN¥173.59 Million | ▲ +347.5% |
| 2014 | 0.09x | CN¥20.22 Million | CN¥237.62 Million | ▼ -68.7% |
| 2013 | 0.27x | CN¥47.34 Million | CN¥174.39 Million | — |